Search research articles
Contact Us
Filters
Showing results (51-60 of 288) with videos related to
Page
of 29
Sort By:
European Journal of Gastroenterology & Hepatology
|
July 13, 2007
Etiologies of chronic liver diseases in Hong Kong
Konrad Tang-Tat Fung, James Fung, Ching-Lung Lai, et al.
Expert Opinion on Drug Safety
|
January 12, 2016
DNA polymerase inhibitors for treating hepatitis B: a safety evaluation
Lung-Yi Mak, Wai-Kay Seto, Ching-Lung Lai, et al.
The Lancet. Infectious Diseases
|
March 28, 2009
Prevention and management of drug resistance for antihepatitis B treatment
Man-Fung Yuen, James Fung, Danny Ka-Ho Wong, et al.
Journal of Clinical Gastroenterology
|
August 13, 2002
Acute hepatitis as a presentation of acute appendicitis in an immunocompromised patient
Chi-Keung Yeung, Man-Fung Yuen, Ching-Lung Lai, et al.
Gut and Liver
|
April 27, 2016
Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region
Ran Xu Zhu, Wai-Kay Seto, Ching-Lung Lai, et al.
Hepatology International
|
January 8, 2016
Prevention and management of hepatitis B virus reactivation in cancer patients
Ka-Shing Cheung, Wai-Kay Seto, Ching-Lung Lai, et al.
Current Hepatitis Reports
|
December 2, 2011
Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety
Yuk-Fai Lam, Man-Fung Yuen, Wai-Kay Seto, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
December 15, 2017
Pharmacokinetic evaluation of besifovir for the treatment of HBV infection
Lung-Yi Mak, Wai-Kay Seto, Ching-Lung Lai, et al.
Expert Opinion on Drug Safety
|
July 29, 2010
Safety evaluation of telbivudine
David Yiu-Kuen But, Man-Fung Yuen, James Fung, et al.
Hepatobiliary Surgery and Nutrition
|
February 27, 2014
Do statins reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis B?
James Fung, Ching-Lung Lai, Man-Fung Yuen, et al.
Page
of 29
Search research articles
Search
Showing results (51-60 of 288) with videos related to
Sort By:
Page
of 29
European Journal of Gastroenterology & Hepatology
|
July 13, 2007
Etiologies of chronic liver diseases in Hong Kong
Konrad Tang-Tat Fung, James Fung, Ching-Lung Lai, et al.
Expert Opinion on Drug Safety
|
January 12, 2016
DNA polymerase inhibitors for treating hepatitis B: a safety evaluation
Lung-Yi Mak, Wai-Kay Seto, Ching-Lung Lai, et al.
The Lancet. Infectious Diseases
|
March 28, 2009
Prevention and management of drug resistance for antihepatitis B treatment
Man-Fung Yuen, James Fung, Danny Ka-Ho Wong, et al.
Journal of Clinical Gastroenterology
|
August 13, 2002
Acute hepatitis as a presentation of acute appendicitis in an immunocompromised patient
Chi-Keung Yeung, Man-Fung Yuen, Ching-Lung Lai, et al.
Gut and Liver
|
April 27, 2016
Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region
Ran Xu Zhu, Wai-Kay Seto, Ching-Lung Lai, et al.
Hepatology International
|
January 8, 2016
Prevention and management of hepatitis B virus reactivation in cancer patients
Ka-Shing Cheung, Wai-Kay Seto, Ching-Lung Lai, et al.
Current Hepatitis Reports
|
December 2, 2011
Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety
Yuk-Fai Lam, Man-Fung Yuen, Wai-Kay Seto, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
December 15, 2017
Pharmacokinetic evaluation of besifovir for the treatment of HBV infection
Lung-Yi Mak, Wai-Kay Seto, Ching-Lung Lai, et al.
Expert Opinion on Drug Safety
|
July 29, 2010
Safety evaluation of telbivudine
David Yiu-Kuen But, Man-Fung Yuen, James Fung, et al.
Hepatobiliary Surgery and Nutrition
|
February 27, 2014
Do statins reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis B?
James Fung, Ching-Lung Lai, Man-Fung Yuen, et al.
Page
of 29